Epilepsy Clinical Trials in Philadelphia, Pennsylvania

6 studies are recruiting for epilepsy in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Diagnosing Epilepsy To EffeCT Change

   The purpose of this research is to address the challenges of diagnosing and long-term management of epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This resear…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   21 in total

   Run by

   Epiminder America, Inc.

   See if you can join NCT07110337 on ClinicalTrials.gov

2. Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

   The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. Thi…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Locations

   18 in total

   Run by

   Epiminder America, Inc.

   See if you can join NCT07110454 on ClinicalTrials.gov

3. Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1

   This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Thomas Jefferson University, Philadelphia, Pennsylvania

   Locations

   11 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07563881 on ClinicalTrials.gov

4. Localizing Epileptic Networks Using MRI and iEEG

   Upon successful completion of this study, the investigators expect the study's contribution to be the development of noninvasive imaging biomarkers to predict IEEG functional dynamics and epilepsy surgical outcomes. Findings from the present study may inform current and new therapies to map and alt…

   Stage

   EARLY_Phase 1

   Ages

   18 and older

   Site

   University of Pennsylvania, Philadelphia, Pennsylvania

   Run by

   University of Pennsylvania

   See if you can join NCT04649008 on ClinicalTrials.gov

5. A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

   This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determine RAP-219 Long- term safety and open-label antiseizure activity in patients with Refractory Focal Epilepsy.

   Stage

   Phase 2

   Ages

   18 to 70

   Site

   University of Pennsylvania - Department of Neurology, Philadelphia, Pennsylvania

   Locations

   7 in total

   Run by

   Rapport Therapeutics Inc.

   See if you can join NCT07219407 on ClinicalTrials.gov

6. Epilepsy Learning Healthcare System (ELHS)

   The Epilepsy Learning Health System (ELHS) is a quality improvement and research network to improve outcomes for people with epilepsy. The ELHS is designed as a model of value-based chronic care for epilepsy as envisioned by the National Academies of Medicine Committee in their landmark reports "Th…

   Stage

   Not phased

   Ages

   Any age

   Site

   Children's Hospital of Philadelphia (CHOP), Philadelphia, Pennsylvania

   Locations

   13 in total

   Run by

   Epilepsy Foundation of America

   See if you can join NCT06265103 on ClinicalTrials.gov